Clinical trial
Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use…
NCT00203528 · Tuscaloosa Research & Education Advancement Corporation, Other · Completed
Key facts
| NCT number | NCT00203528 |
|---|---|
| Title | Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder |
| Official title | Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder |
| Lead sponsor | Tuscaloosa Research & Education Advancement Corporation, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Substance Abuse, Bipolar Depression |
| Intervention type | Drug |
| Interventions | divalproex sodium ER, risperidone |
| Enrollment | 30 |
| Start date | Jan 1, 2004 |
| Completion | Feb 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 19, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: